(Q51565261)

7 April 2018

review article

1 reference

title

Drug therapy of postprandial hyperglycaemia. (English)

1 reference

7 April 2018

1 reference

A D Mooradian

1

1 reference

7 April 2018

J E Thurman

series ordinal

2

1 reference

7 April 2018

publication date

1 January 1999

1 reference

7 April 2018

published in

Drugs

1 reference

7 April 2018

volume

57

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

page(s)

19-29

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.2165/00003495-199957010-00003

exact match

0 references

cites work

Dose-response for glucagonostatic effect of amylin in rats

1 reference

12 December 2020

Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue.

1 reference

12 December 2020

Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM

1 reference

12 December 2020

Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.

1 reference

12 December 2020

A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey

1 reference

12 December 2020

Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians.

1 reference

12 December 2020

Relationship between gastric emptying and an alpha-glucosidase inhibitor effect on postprandial hyperglycemia in NIDDM patients.

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Effect of a new hypoglycemic agent, A-4166 [(-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine], on postprandial blood glucose excursion: comparison with voglibose and glibenclamide

1 reference

12 December 2020

Decrease of Stimulated Amylin Release Precedes Impairment of Insulin Secretion in Type II Diabetes

1 reference

12 December 2020

Hypersecretion of amylin from the perfused pancreas of genetically obese (fa/fa) rats and its alteration with aging

1 reference

12 December 2020

Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study

1 reference

12 December 2020

Does hyperglycemia really cause coronary heart disease?

1 reference

12 December 2020

Influence of aging on hepatic and peripheral glucose metabolism in humans.

1 reference

12 December 2020

Improvement of insulin sensitivity and dyslipidemia with a new alpha-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects

1 reference

12 December 2020

[Lys(B28), Pro(B29)]-human insulin: effect of injection time on postprandial glycemia

1 reference

12 December 2020

Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency

1 reference

12 December 2020

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

1 reference

12 December 2020

The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics

1 reference

12 December 2020

PROTECT interim results: a large multicenter study of patients with type II diabetes. Precose Resolution of Optimal Titration to Enhance Current Therapies

1 reference

12 December 2020

1 reference

12 December 2020

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effect of 1-desoxynojirimycin derivatives on small intestinal disaccharidase activities and on active transport in vitro.

1 reference

12 December 2020

The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone

1 reference

12 December 2020

Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women.

1 reference

12 December 2020

Effects of amylin and the amylin agonist pramlintide on glucose metabolism

1 reference

12 December 2020

The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes

1 reference

12 December 2020

Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone

1 reference

12 December 2020

Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.

1 reference

12 December 2020

Effects of acarbose on fecal nutrients, colonic pH, and short-chain fatty acids and rectal proliferative indices

1 reference

12 December 2020

Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Amylin regulation of carbohydrate metabolism.

1 reference

12 December 2020

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

12 December 2020

Insulin and Cardiovascular Disease: Paris Prospective Study

1 reference

12 December 2020

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial

1 reference

12 December 2020

Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.

1 reference

12 December 2020

Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition

1 reference

12 December 2020

Incidence of Diabetic Retinopathy and Relationship to Baseline Plasma Glucose and Blood Pressure

1 reference

12 December 2020

Effect of simple carbohydrates, casein hydrolysate, and a lipid test meal on ethane exhalation rate.

1 reference

12 December 2020

Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program

1 reference

12 December 2020

The glycemic effect of different meals approximately isocaloric and similar in protein, carbohydrate, and fat content as calculated using the ADA exchange lists

1 reference

12 December 2020

The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?

1 reference

12 December 2020

The glycaemic index of foods tested in diabetic patients: a new basis for carbohydrate exchange favouring the use of legumes

1 reference

12 December 2020

Islet amyloid polypeptide/amylin contents in pancreata increase in genetically obese and diabetic mice

1 reference

12 December 2020

Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus

1 reference

12 December 2020

The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population.

1 reference

12 December 2020

Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.

1 reference

12 December 2020

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

1 reference

12 December 2020

Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load

1 reference

12 December 2020

The postprandial state and the risk of atherosclerosis

1 reference

12 December 2020

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group

1 reference

12 December 2020

Hyperglycaemia and diabetes mellitus

1 reference

12 December 2020

Pharmacology of alpha-glucosidase inhibition.

1 reference

12 December 2020

Beneficial effects of acarbose in the atherosclerosis-prone JCR:LA-corpulent rat.

1 reference

12 December 2020

Beneficial effect of a low glycaemic index diet in type 2 diabetes.

1 reference

12 December 2020

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

1 reference

12 December 2020

Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects

1 reference

12 December 2020

Effect of diabetes, insulin, and glucose load on lipid peroxidation in the rat

1 reference

12 December 2020

Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion

1 reference

12 December 2020

Autoxidative and antioxidative potential of simple carbohydrates

1 reference

12 December 2020

alpha-Glucosidase inhibition by miglitol in NIDDM patients

1 reference

12 December 2020

Dietary fiber in the management of diabetes

1 reference

12 December 2020

Insulin and cognitive function in an elderly population. The Rotterdam Study.

1 reference

12 December 2020

Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study

1 reference

12 December 2020

Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients

1 reference

12 December 2020

Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.

1 reference

12 December 2020

Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy

1 reference

12 December 2020

Sudden death, impaired glucose tolerance, and diabetes in Japanese American men.

1 reference

12 December 2020

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions

1 reference

12 December 2020

Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients

1 reference

12 December 2020

Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance

1 reference

12 December 2020

Stimulation of insulin release by non-sulfonylurea hypoglycemic agents: the meglitinide family

1 reference

12 December 2020

Plasma glucose and insulin profiles in normal subjects ingesting diets of varying carbohydrate, fat, and protein content

1 reference

12 December 2020

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

1 reference

12 December 2020

1 reference

12 December 2020

Amylin concentrations and glucose control

1 reference

12 December 2020

Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve

1 reference

12 December 2020

Nutrition principles for the management of diabetes and related complications

1 reference

12 December 2020

10.2165/00003495-199957010-00003

Identifiers

DOI

1 reference

7 April 2018

Dimensions Publication ID

1030041223

0 references

Fatcat ID

release_rb3dkzajh5e3npmq3sefslicoa

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rb3dkzajh5e3npmq3sefslicoa

24 November 2022

mapped directly with Wikidata item

PubMed ID

9951949

1 reference

7 April 2018